Assembly Biosciences Stock In The News

ASMB Stock  USD 14.43  0.57  4.11%   
Our overall analysis of Assembly Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Assembly Biosciences. The specific impact of Assembly Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Assembly Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Assembly Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Assembly Biosciences Backtesting and Assembly Biosciences Hype Analysis.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.

Assembly Biosciences Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
https://www.globenewswire.com/news-release/2023/11/10/2778507/16259/en/Assembly-Biosciences-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
 Bullish
Macroaxis News: globenewswire.com
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio at AASLD The Liver Meeting®
https://www.globenewswire.com/news-release/2023/11/10/2778276/16259/en/Assembly-Biosciences-Presents-New-Data-Highlighting-Viral-Hepatitis-Portfolio-at-AASLD-The-Liver-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Assembly Biosciences Reports Third Quarter 2023 Financial Results and Recent Updates
https://www.globenewswire.com/news-release/2023/11/08/2776699/16259/en/Assembly-Biosciences-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Updates.html
 Bullish
Macroaxis News: globenewswire.com
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
https://www.globenewswire.com/news-release/2023/11/08/2776175/16259/en/Assembly-Biosciences-Names-Anuj-Gaggar-MD-PhD-as-Chief-Medical-Officer.html
 Bullish
Yahoo News
Gilead and Assembly Biosciences Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
https://finance.yahoo.com/news/gilead-assembly-biosciences-establish-partnership-110000902.html
 Neutral
Macroaxis News: globenewswire.com
Assembly Biosciences to Present New Data at AASLD The Liver Meeting®
https://www.globenewswire.com/news-release/2023/10/11/2758302/16259/en/Assembly-Biosciences-to-Present-New-Data-at-AASLD-The-Liver-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Assembly Biosciences Nominates Development Candidate ABI-6250, an Orally Bioavailable HDV Entry Inhibitor
https://www.globenewswire.com/news-release/2023/10/02/2752700/16259/en/Assembly-Biosciences-Nominates-Development-Candidate-ABI-6250-an-Orally-Bioavailable-HDV-Entry-Inhibitor.html
 Neutral
Macroaxis News: globenewswire.com
Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting
https://www.globenewswire.com/news-release/2023/09/19/2746015/16259/en/Assembly-Biosciences-to-Highlight-Pipeline-Progress-in-HBV-and-HDV-at-the-2023-International-HBV-Meeting.html
 Neutral
Macroaxis News: globenewswire.com
Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates
https://www.globenewswire.com/news-release/2023/08/09/2722123/16259/en/Assembly-Biosciences-Reports-Second-Quarter-2023-Financial-Results-and-Recent-Updates.html
 Neutral
Macroaxis News: globenewswire.com
Assembly Biosciences Presents New Data H...
https://www.globenewswire.com/news-release/2023/07/17/2705546/16259/en/Assembly-Biosciences-Presents-New-Data-Highlighting-Herpes-Simplex-Virus-Development-Candidate-ABI-5366-at-the-47th-Annual-International-Herpesvirus-Workshop.html
 Neutral

Assembly Biosciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Assembly and other traded companies coverage with news coverage. We help investors stay connected with Assembly headlines for the 31st of January to make an informed investment decision based on correlating the impacts of news items on Assembly Stock performance. Please note that trading solely based on the Assembly Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Assembly Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Assembly Biosciences investors visualize upcoming and past events in order to time the market based on Assembly Biosciences noise-free hype analysis.
Assembly Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Assembly earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Assembly Biosciences that are available to investors today. That information is available publicly through Assembly media outlets and privately through word of mouth or via Assembly internal channels. However, regardless of the origin, that massive amount of Assembly data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Assembly Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Assembly Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Assembly Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Assembly Biosciences alpha.

Assembly Largest EPS Surprises

Earnings surprises can significantly impact Assembly Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-08-09
2023-06-30-0.29-0.32-0.0310 
2023-11-08
2023-09-30-0.23-0.27-0.0417 
2022-03-10
2021-12-31-0.48-0.380.120 
2021-05-06
2021-03-31-0.79-0.690.112 
2021-08-05
2021-06-30-0.66-0.550.1116 
2019-02-28
2018-12-31-0.9-1.03-0.1314 
View All Earnings Estimates

Assembly Biosciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Assembly Biosciences Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
news
17th of January 2025
Arvind Kejriwal Seeks Discount For Students In Delhi Metro, Writes To PM Modi
at ndtv.com 
news
16th of January 2025
Fact-check Did Gavin Newsom cut 100m in fire prevention funding
at aljazeera.com 
news
15th of January 2025
Firm Up A 5-Year Plan, Prepare For Next Polls PM Modi To Maharashtra Legislators
at ndtv.com 
news
13th of January 2025
Hochul pitches plans for universal free school meals
at aol.com 
news
10th of January 2025
Windsor Framework review must be honest assessment of problems Robinson
at independent.co.uk 
news
7th of January 2025
Delhi Assembly Elections 2025 Date Announcement Live Updates Schedule To Be Released Short...
at ndtv.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Assembly Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Assembly Biosciences' short interest history, or implied volatility extrapolated from Assembly Biosciences options trading.
When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:
Check out Assembly Biosciences Backtesting and Assembly Biosciences Hype Analysis.
For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.89)
Revenue Per Share
4.125
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.35)
Return On Equity
(1.02)
The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.